AUTL (STOCKS)
Autolus Therapeutics plc American Depositary Share
$1.439900
+0.009900 (+0.69%)
Prev close: $1.430000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Christian Martin Itin
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $380.58M
- Employees
- 647
- P/E (TTM)
- -1.69
- P/B (TTM)
- 1.91
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
10
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.30 | $-0.23 | -0.0698 | -30.32% |
|
Jun 2025 (Q2)
|
$-0.18 | $-0.24 | +0.0604 | +25.12% |
|
Mar 2025 (Q1)
|
$-0.26 | $-0.26 | -0.0050 | -1.96% |
|
Dec 2024 (Q4)
|
$-0.10 | $-0.21 | +0.1098 | +52.34% |
Financial Statements
| Revenues | $51.13M |
| Benefits Costs and Expenses | $271.31M |
| Cost Of Revenue | $82.43M |
| Costs And Expenses | $271.31M |
| Nonoperating Income/Loss | $53.76M |
| Operating Expenses | $242.64M |
| Selling, General, and Administrative Expenses | $129.76M |
| Research and Development | $112.89M |
| Other Operating Expenses | $3.00K |
| Operating Income/Loss | -$273.94M |
| Income/Loss From Continuing Operations After Tax | -$224.80M |
| Income/Loss From Continuing Operations Before Tax | -$220.19M |
| Income Tax Expense/Benefit | $4.62M |
| Interest Expense, Operating | -$17.00M |
| Net Income/Loss | -$224.80M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$224.80M |
| Net Income/Loss Available To Common Stockholders, Basic | -$224.80M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.83 |
| Diluted Earnings Per Share | -$0.83 |
| Basic Average Shares | 802,089,907 |
| Diluted Average Shares | 802,089,907 |
| Assets | $661.95M |
| Current Assets | $514.58M |
| Inventory | $27.72M |
| Prepaid Expenses | $23.21M |
| Other Current Assets | $463.65M |
| Noncurrent Assets | $147.37M |
| Fixed Assets | $66.85M |
| Other Non-current Assets | $80.52M |
| Liabilities | $396.50M |
| Current Liabilities | $83.07M |
| Accounts Payable | $10.97M |
| Wages | $22.61M |
| Other Current Liabilities | $49.49M |
| Noncurrent Liabilities | $313.42M |
| Equity | $265.45M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $265.45M |
| Liabilities And Equity | $661.95M |
| Net Cash Flow From Operating Activities | -$254.18M |
| Net Cash Flow From Operating Activities, Continuing | -$254.18M |
| Net Cash Flow From Investing Activities | -$311.67M |
| Net Cash Flow From Investing Activities, Continuing | -$311.67M |
| Net Cash Flow From Financing Activities | $27.47M |
| Net Cash Flow From Financing Activities, Continuing | $27.47M |
| Exchange Gains/Losses | -$32.53M |
| Net Cash Flow | -$570.91M |
| Net Cash Flow, Continuing | -$538.39M |
| Comprehensive Income/Loss | -$228.82M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$228.82M |
| Other Comprehensive Income/Loss | -$4.02M |
| Other Comprehensive Income/Loss Attributable To Parent | -$4.02M |